Cholangiocellular Carcinoma Detection on CCA Dataset
100SensitivitypCEA
Evaluation results
| Method | Links | ||
|---|---|---|---|
| pCEAReference Study=[2], Positive Staining Pattern Definition=membranous and/or cytoplasmic2026.07 | 100 | — | |
| pCEAReference Study=[5], Positive Staining Pattern Definition=membranous and/or cytoplasmic2026.07 | 100 | — | |
| MOC 31Reference Study=[19]2026.07 | 100 | — | |
| CK7Reference Study=[17]2026.07 | 100 | — | |
| nnU-Net2026.07 | 99 | — | |
| CK7Reference Study=[20]2026.07 | 97 | — | |
| MOC 31Reference Study=[5]2026.07 | 93 | — | |
| CK19Reference Study=[17]2026.07 | 80 | — | |
| CK7Reference Study=[2]2026.07 | 78 | — | |
| CK19Reference Study=[20]2026.07 | 77 | — | |
| MOC 31Reference Study=[2]2026.07 | 67 | — | |
| CK19Reference Study=[2]2026.07 | 44 | — | |
| CK8/18Reference Study=[17]2026.07 | 20 | — | |
| GPC3Reference Study=[15]2026.07 | 19 | — | |
| Hep Par 1Reference Study=[6]2026.07 | 12.5 | — | |
| CK20Reference Study=[2]2026.07 | 11 | — | |
| GPC3Reference Study=[7]2026.07 | 10 | — | |
| CK20Reference Study=[20]2026.07 | 10 | — | |
| Hep Par 1Reference Study=[4]2026.07 | 9 | — | |
| Hep Par 1Reference Study=[3]2026.07 | 7 | — | |
| Hep Par 1Reference Study=[2]2026.07 | 0 | — | |
| Hep Par 1Reference Study=[5]2026.07 | 0 | — | |
| Hep Par 1Reference Study=[1]2026.07 | 0 | — | |
| GPC3Reference Study=[12]2026.07 | 0 | — |